Descriptor English: | Gemfibrozil | ||||||
Descriptor Spanish: |
Gemfibrozilo
| ||||||
Descriptor Portuguese: | Genfibrozila | ||||||
Descriptor French: | Gemfibrozil | ||||||
Entry term(s): |
Apo Gemfibrozil Apo-Gemfibrozil ApoGemfibrozil Ausgem Bayvit, Gemfibrozilo Bolutol CI 719 CI-719 CI719 Chem mart Gemfibrozil DBL Gemfibrozil Decrelip Gemfi 1A Pharma Gemfibrosil Gemfibrozil, GenRX Gemfibrozil, Healthsense Gemfibrozil, SBPA Gemfibrozilo Bayvit Gemfibrozilo Bexal Gemfibrozilo Ur Gemhexal Gen Gemfibrozil Gen-Gemfibrozil GenGemfibrozil GenRX Gemfibrozil Healthsense Gemfibrozil Jezil Lipazil Lipox Gemfi Lipur Litarek Lopid Lopid R Novo Gemfibrozil Novo-Gemfibrozil Nu Gemfibrozil Nu-Gemfibrozil NuGemfibrozil PMS Gemfibrozil PMS-Gemfibrozil Pilder SBPA Gemfibrozil Terry White Chemists Gemfibrozil Trialmin |
||||||
Tree number(s): |
D02.241.081.114.968.500.750 D02.241.081.944.509.350 D02.355.726.305.750 D02.455.426.559.389.657.654.305.750 D10.251.400.895.593.350 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015248 | ||||||
Scope note: | A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Hypolipidemic Agents Cytochrome P-450 CYP2C8 Inhibitors |
||||||
Registry Number: | Q8X02027X3 | ||||||
CAS Type 1 Name: | Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl- | ||||||
Previous Indexing: |
Pentanoic Acids (1975-1988) Valerates (1966-1974) |
||||||
Public MeSH Note: | 89 |
||||||
History Note: | 89 |
||||||
DeCS ID: | 23643 | ||||||
Unique ID: | D015248 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1989/01/01 | ||||||
Date of Entry: | 1988/05/16 | ||||||
Revision Date: | 2016/07/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Lipids [D10]Lipids
|
Gemfibrozil
- Preferred
Ausgem
- Narrower
Bolutol
- Narrower
Chem mart Gemfibrozil
- Narrower
CI-719
- Narrower
DBL Gemfibrozil
- Narrower
Decrelip
- Narrower
Gemfi 1A Pharma
- Narrower
Gemfibrozilo Bayvit
- Narrower
Gemfibrozilo Bexal
- Narrower
Gemfibrozilo Ur
- Narrower
Gemhexal
- Narrower
Gen-Gemfibrozil
- Narrower
GenRX Gemfibrozil
- Narrower
Healthsense Gemfibrozil
- Narrower
Jezil
- Narrower
Lipazil
- Narrower
Lipox Gemfi
- Narrower
Litarek
- Narrower
Lopid
- Narrower
Novo-Gemfibrozil
- Narrower
Nu-Gemfibrozil
- Narrower
Pilder
- Narrower
PMS-Gemfibrozil
- Narrower
SBPA Gemfibrozil
- Narrower
Terry White Chemists Gemfibrozil
- Narrower
Trialmin
- Narrower
Apo-Gemfibrozil
- Narrower
Concept UI |
M0023484 |
Scope note | A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. |
Preferred term | Gemfibrozil |
Entry term(s) |
Gemfibrosil |
Concept UI |
M0482981 |
Preferred term | Ausgem |
Concept UI |
M0482982 |
Preferred term | Bolutol |
Concept UI |
M0482983 |
Preferred term | Chem mart Gemfibrozil |
Concept UI |
M0333445 |
Preferred term | CI-719 |
Entry term(s) |
CI 719 CI719 |
Concept UI |
M0482984 |
Preferred term | DBL Gemfibrozil |
Concept UI |
M0482985 |
Preferred term | Decrelip |
Concept UI |
M0482986 |
Preferred term | Gemfi 1A Pharma |
Concept UI |
M0482987 |
Preferred term | Gemfibrozilo Bayvit |
Entry term(s) |
Bayvit, Gemfibrozilo |
Concept UI |
M0482988 |
Preferred term | Gemfibrozilo Bexal |
Concept UI |
M0482989 |
Preferred term | Gemfibrozilo Ur |
Concept UI |
M0482990 |
Preferred term | Gemhexal |
Concept UI |
M0482991 |
Preferred term | Gen-Gemfibrozil |
Entry term(s) |
Gen Gemfibrozil GenGemfibrozil |
Concept UI |
M0482992 |
Preferred term | GenRX Gemfibrozil |
Entry term(s) |
Gemfibrozil, GenRX |
Concept UI |
M0482993 |
Preferred term | Healthsense Gemfibrozil |
Entry term(s) |
Gemfibrozil, Healthsense |
Concept UI |
M0482994 |
Preferred term | Jezil |
Concept UI |
M0482995 |
Preferred term | Lipazil |
Concept UI |
M0482996 |
Preferred term | Lipox Gemfi |
Concept UI |
M0482997 |
Preferred term | Litarek |
Concept UI |
M0023485 |
Preferred term | Lopid |
Entry term(s) |
Lipur Lopid R |
Concept UI |
M0482998 |
Preferred term | Novo-Gemfibrozil |
Entry term(s) |
Novo Gemfibrozil |
Concept UI |
M0483084 |
Preferred term | Nu-Gemfibrozil |
Entry term(s) |
Nu Gemfibrozil NuGemfibrozil |
Concept UI |
M0483085 |
Preferred term | Pilder |
Concept UI |
M0483086 |
Preferred term | PMS-Gemfibrozil |
Entry term(s) |
PMS Gemfibrozil |
Concept UI |
M0483087 |
Preferred term | SBPA Gemfibrozil |
Entry term(s) |
Gemfibrozil, SBPA |
Concept UI |
M0483088 |
Preferred term | Terry White Chemists Gemfibrozil |
Concept UI |
M0483089 |
Preferred term | Trialmin |
Concept UI |
M0482980 |
Preferred term | Apo-Gemfibrozil |
Entry term(s) |
Apo Gemfibrozil ApoGemfibrozil |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey